Influential Factors in Adherence to the Therapeutic Regime in Hypertension and Diabetes


  • Dora Inés Parra Nurse, Masters. Professor, Universidad Industrial de Santander, Bucaramanga, Colombia. Email: doipa-
  • Sandra Lucrecia Romero Guevara Nurse, Masters. Professor, Universidad Industrial de Santander, Bucaramanga, Colombia. Email: saluro-
  • Lyda Z Rojas Nurse, PhD. Professor, Universidad Industrial de Santander, Bucaramanga, Colombia. Email: lyda.



Treatment adherence and compliance, hypertension, diabetes mellitus, type 2, risk factors, cross-sectional studies.


Objective. To determine the factors associated with adherence to the therapeutic regime in patients with hypertension and type 2 diabetes mellitus cared for in primary care centers.

Methods. This was an analytical cross-sectional study, conducted with 500 patients from two institutions in Bucaramanga (Colombia). Adherence to the therapeutic regime was measured with the label of Nursing outcomes “Treatment Behavior: Illness or Injury” and the instrument “Factors that influence on adherence to pharmacological and non-pharmacological treatments” by Ortiz Suárez was used.

Results. Factors affecting negatively adherence to the therapeutic regime were: belonging to the subsidized regime, never being able to read written information about the management of their disease, and never receiving information about benefits of the medications ordered by the physician. On the contrary, positive influence was noted by referring “never” to the following statements, which impacted positively on adherence: the diverse occupations you have in and out of the house hinder your following the treatment; when your symptoms improve, do you interrupt the treatment? previously, have you had difficulties in complying with your treatment and believe there are difficult-to-change customs about foods and exercises?

Conclusion. Two socioeconomic factors and one related with the health system and staff affected negatively on adherence to the therapeutic regime, while four factors related with the therapy favored it. The factors identified could be used in the design of nursing interventions to improve adherence in this population.

How to cite this article: Parra DI, Romero SL, Rojas LZ. Influential Factors in Adherence to the Therapeutic Regime in Hypertension and Diabetes. Invest. Educ. Enferm. 2019; 37(3):e02.

= 1425 veces | PDF
= 1060 veces| | HTML ENGLISH
= 0 veces| | HTML SPANISH
= 0 veces| | VIDEO
= 0 veces| | PMC
= 0 veces|


Download data is not yet available.


Metrics Loading ...


(1) Organización Mundial de la Salud. Adherencia a los tratamientos a largo plazo: pruebas para la acción [Internet]. Ginebra: Organización Mundial de la Salud; 2004 [cited 2 Oct 2018]. Available from:

(2) Sandy R, Connor U. Variation in medication adherence across patient behavioral segments: a multi-country study in hypertension. Patient Prefer. Adherence. 2015; 9:1539-48.

(3) Conthea P, Márquez E, Aliaga A, Barragán B, Fernández MN, González M, Ollero M, Pinto JL. Adherencia terapéutica en la enfermedad crónica: estado de la situación y perspectiva de futuro. Rev. Clin. Esp. 2014; 214(6):336-44.

(4) Tang KL, Quan H, Rabi DM. Measuring medication adherence in patients with incident hypertension: a retrospective cohort study. BMC Health Serv. Res. 2017; 17(1):135.

(5) Krass I, Schieback P, Dhippayom T. Adherence to diabetes medication: a systematic review. Diabet. Med. 2015; 32(6): 725-37.

(6) Saleh F, Mumu SJ, Ara F, Hafez MA, Ali L. Non-adherence to self-care practices & medication and health related quality of life among patients with type 2 diabetes: a cross-sectional study. BMC Public Health. 2014; 14:431.

(7) Mumu S, Saleh F, Ara F, Afnan F, Ali L. Non-adherence to life-style modification and its factors among type 2 diabetic patients. Indian J. Public Health. 2014; 58(1):40-4.

(8) Tibebu A, Mengistu D, Negesa L. Adherence to recommended lifestyle modifications and factors associated for hypertensive patients attending chronic follow-up units of selected public hospitals in Addis Ababa, Ethiopia. Patient Prefer. Adherence. 2017; 11:323–30.

(9) Khunti K, Kosiborod M, Ray KK. Legacy benefits of blood glucose, blood pressure and lipid control in individuals with diabetes and cardiovascular disease: Time to overcome multifactorial therapeutic inertia? Diab. Obes. Metab. 2018; 20(6):1337-41.

(10) López Romero LA, Romero SL, Parra DI, Rojas LZ. Adherencia al tratamiento: Concepto y medición. Hacia Promoc. Salud. 2016; 21(1):117-37.

(11) Leung AA, Daskalopoulou SS, Dasgupta K, McBrien K, Butalia S, Zarnke KB, et al. Hypertension Canada’s 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults. Can. J. Cardiol. 2017; 33(5):557-76.

(12) McGuire H, Longson D, Adler A, Farmer A, Lewin I. Guideline Development Group. Management of type 2 diabetes in adults: summary of updated NICE guidance. BMJ. 2016; 353:i1575.

(13) Georgiopoulos G, Kollia Z, Katsi V, Oikonomou D, Tsioufis C, Tousoulis D. Nurse’s Contribution to Alleviate Non-adherence to Hypertension Treatment. Curr. Hypertens. Rep. 2018; 20:65.

(14) Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 1987; 40(5):373-83.

(15) D’Agostino Ralph B., Vasan Ramachandran S., Pencina Michael J., Wolf Philip A., Cobain Mark, Massaro Joseph M., et al. General Cardiovascular Risk Profile for Use in Primary Care. Circulation. 2008; 117(6):743-53.

(16) Moorhead S. Clasificación de resultados de enfermería (NOC). 4th Ed. España: Elsevier Health Sciences; 2008.

(17) Suárez CO. Instrumento para evaluar la adherencia a tratamientos en pacientes con factores de riesgo cardiovascular. Av. Enferm. 2010; 28(2):73-87.

(18) Castaño-Castrillón JJ, Echeverri-Rubio C, Giraldo-Cardona JF, Maldonado-Mora Á, Melo-Parra J, Meza-Orozco GA, et al. Adherencia al tratamiento de pacientes hipertensos atendidos en Assbasalud E.S.E, Manizales (Colombia) 2011. Rev. Fac. Med. 2012; 60(3):179-97.

(19) Ghembaza MA, Senoussaoui Y, Tani MK, Meguenni K. Impact of patient knowledge of hypertension complications on adherence to antihypertensive therapy. Curr. Hypertens. Rev. 2014; 10(1):41-8.

(20) Rodríguez-Abt JC, Solís-Visscher RJ, Rogic-Valencia SJ, Román Y, Reyes-Rocha M. Asociación entre conocimiento de hipertensión arterial y adherencia al tratamiento en pacientes hipertensos del Hospital Nacional Edgardo Rebagliati Martins de Lima, Perú. 2015. Rev. Fac. Med. 2017; 65(1):55-60.

(21) Bhandari B, Bhattarai M, Bhandari M, Ghimire A, Pokharel PK, Morisky DE. Adherence to Antihypertensive Medications: Population Based Follow up in Eastern Nepal. J. Nepal Health Res. Counc. 2015; 13(29):38-42.

(22) Marshall IJ, Wolfe CDA, McKevitt C. Lay perspectives on hypertension and drug adherence: systematic review of qualitative research. BMJ. 2012; 345: e3953.

(23) Forechi L, Mill JG, Griep RH, Santos I, Pitanga F, Molina M. Adherence to physical activity in adults with chronic diseases: ELSA-Brasil. Rev. Saúde Pública. 2018; 52:31.

(24) Alefishat EA, Abu Farha RK, Al-Debe MM. Self-Reported Adherence among Individuals at High Risk of Metabolic Syndrome: Effect of Knowledge and Attitude. Med. Princ. Pract. 2017; 26:157–63.

(25) Cano-Serna DA, Correa-Bolívar NA, Flórez-Rendón WA, Giraldo-Giraldo YD, Monsalve-Cuervo MK, Restrepo-Otálvaro AF. Management of resources in nursing: beyond leadership. Our will to be and do. Invest. Educ. Enferm. 2013; 31(2):315-8.



How to Cite

Parra, D. I., Romero Guevara, S. L., & Rojas, L. Z. (2019). Influential Factors in Adherence to the Therapeutic Regime in Hypertension and Diabetes. Investigación Y Educación En Enfermería, 37(3).




Similar Articles

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 > >> 

You may also start an advanced similarity search for this article.